# The EarLens Contact Hearing Device (CHD) Spectrum Study

> **NCT02470494** · NA · COMPLETED · sponsor: **EarLens Corporation** · enrollment: 46 (actual)

## Conditions studied

- Hearing Loss, Sensorineural

## Interventions

- **DEVICE:** Sound amplification provided via the EarLens CHD

## Key facts

- **NCT ID:** NCT02470494
- **Lead sponsor:** EarLens Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-06
- **Primary completion:** 2016-06
- **Final completion:** 2016-11
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-06-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02470494

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02470494, "The EarLens Contact Hearing Device (CHD) Spectrum Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02470494. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*